AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 82 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2020. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | -100.0% | 48 | -99.9% | 0.00% | -100.0% |
Q2 2023 | $813 | -18.7% | 49,335 | +31935.7% | 0.00% | – |
Q3 2021 | $1,000 | -75.0% | 154 | -78.2% | 0.00% | – |
Q2 2021 | $4,000 | -96.9% | 708 | -95.0% | 0.00% | – |
Q1 2021 | $130,000 | +36.8% | 14,303 | +0.6% | 0.00% | – |
Q4 2020 | $95,000 | +33.8% | 14,215 | +1.4% | 0.00% | – |
Q3 2020 | $71,000 | -78.4% | 14,015 | -65.5% | 0.00% | – |
Q2 2020 | $328,000 | +195.5% | 40,615 | +189.1% | 0.00% | – |
Q1 2020 | $111,000 | – | 14,049 | +200600.0% | 0.00% | – |
Q1 2019 | $0 | – | 7 | -90.8% | 0.00% | – |
Q4 2018 | $0 | -100.0% | 76 | -65.6% | 0.00% | – |
Q3 2018 | $1,000 | -88.9% | 221 | -85.5% | 0.00% | – |
Q2 2018 | $9,000 | -83.0% | 1,521 | -79.4% | 0.00% | – |
Q1 2018 | $53,000 | -13.1% | 7,371 | -2.6% | 0.00% | – |
Q4 2017 | $61,000 | +41.9% | 7,570 | +86.2% | 0.00% | – |
Q3 2017 | $43,000 | +26.5% | 4,065 | +32.6% | 0.00% | – |
Q2 2017 | $34,000 | – | 3,065 | +4615.4% | 0.00% | – |
Q1 2017 | $0 | – | 65 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 1,625,000 | $12,269,000 | 3.04% |
GENDELL JEFFREY L | 1,146,764 | $8,658,000 | 1.11% |
Broadfin Capital, LLC | 1,029,012 | $7,769,000 | 1.04% |
RTW INVESTMENTS, LP | 3,401,434 | $25,681,000 | 0.97% |
BRANDES INVESTMENT PARTNERS, LP | 3,651,948 | $27,571,000 | 0.66% |
Aristides Capital LLC | 71,520 | $540,000 | 0.42% |
Tekla Capital Management LLC | 814,588 | $6,150,000 | 0.23% |
INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV | 36,100 | $273,000 | 0.17% |
Leap Investments LP | 43,481 | $328,000 | 0.15% |
Brown Capital Management | 1,829,886 | $13,816,000 | 0.13% |